Effect of serum lipid levels on stroke outcome after rt-PA therapy: SAMURAI rt-PA registry - PubMed (original) (raw)
Multicenter Study
doi: 10.1159/000334664. Epub 2012 Jan 19.
Yasushi Okada, Masatoshi Koga, Yoshiaki Shiokawa, Jyoji Nakagawara, Eisuke Furui, Kazumi Kimura, Hiroshi Yamagami, Yasuhiro Hasegawa, Kazuomi Kario, Satoshi Okuda, Masaki Naganuma, Kazunori Toyoda
Affiliations
- PMID: 22261711
- DOI: 10.1159/000334664
Multicenter Study
Effect of serum lipid levels on stroke outcome after rt-PA therapy: SAMURAI rt-PA registry
Noriko Makihara et al. Cerebrovasc Dis. 2012.
Abstract
Background: The effects of lipid levels on clinical outcomes after ischemic stroke are controversial. Whether admission lipid levels and prior statin use are associated with early intracerebral hemorrhage (ICH) and long-term functional outcome after recombinant tissue plasminogen activator (rt-PA) therapy for stroke patients was investigated.
Methods: Ischemic stroke patients who received intravenous rt-PA from a multicenter registry were studied. Lipid levels on admission, including total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol, and triglyceride levels, as well as prior statin use, were assessed. The primary outcome was favorable outcome at 3 months corresponding to a modified Rankin Scale score ≤1. The secondary outcome was any or symptomatic ICH within the initial 36 h.
Results: Of 489 enrolled patients (171 women, 70.8 ± 11.6 years old), 60 used statins prior to stroke, 93 developed ICH (19.0%), and 188 (38.4%) had a favorable 3-month outcome. Of the lipid levels, only the HDL-C level was an independent predictor of favorable outcome after multivariate adjustment for baseline characteristics (OR 1.95, 95% CI 1.10-3.47 per 1 mmol/l; p = 0.023) and after further adjustment for pretreatment radiological findings (OR 2.03, 95% CI 1.07-3.84; p = 0.029). For the 187 stroke patients without cardioembolism, the HDL-C level was more strongly associated with favorable outcome (OR 4.94, 95% CI 1.91-12.76 per 1 mmol/l; p = 0.001). There were no significant associations between ICH and any lipid levels. Prior statin use was not associated with outcomes.
Conclusions: The admission HDL-C level was associated with favorable outcome 3 months after intravenous rt-PA therapy in stroke patients without cardioembolism.
Copyright © 2012 S. Karger AG, Basel.
Similar articles
- Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
Mori M, Naganuma M, Okada Y, Hasegawa Y, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Kario K, Okuda S, Koga M, Minematsu K, Toyoda K. Mori M, et al. Cerebrovasc Dis. 2012;34(2):140-6. doi: 10.1159/000339759. Epub 2012 Aug 1. Cerebrovasc Dis. 2012. PMID: 22854333 - Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PA: SAMURAI rt-PA Registry.
Nezu T, Koga M, Kimura K, Shiokawa Y, Nakagawara J, Furui E, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Naganuma M, Minematsu K, Toyoda K. Nezu T, et al. Neurology. 2010 Aug 10;75(6):555-61. doi: 10.1212/WNL.0b013e3181eccf78. Neurology. 2010. PMID: 20697108 - Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
Koga M, Arihiro S, Miyashita F, Yamamoto H, Yamada N, Nagatsuka K, Minematsu K, Toyoda K. Koga M, et al. Cerebrovasc Dis. 2013;36(4):299-305. doi: 10.1159/000355054. Epub 2013 Oct 16. Cerebrovasc Dis. 2013. PMID: 24135558 - Cholesterol levels and risk of hemorrhagic stroke: a systematic review and meta-analysis.
Wang X, Dong Y, Qi X, Huang C, Hou L. Wang X, et al. Stroke. 2013 Jul;44(7):1833-9. doi: 10.1161/STROKEAHA.113.001326. Epub 2013 May 23. Stroke. 2013. PMID: 23704101 Review. - [Evaluation for antithrombotic agents by a thrombotic model in animals].
Suzuki Y. Suzuki Y. Yakugaku Zasshi. 2012;132(9):1019-24. doi: 10.1248/yakushi.132.1019. Yakugaku Zasshi. 2012. PMID: 23023418 Review. Japanese.
Cited by
- Statin, cholesterol, and sICH after acute ischemic stroke: systematic review and meta-analysis.
Tan C, Liu X, Mo L, Wei X, Peng W, Wang H, Zhou W, Jiang J, Chen Y, Chen L. Tan C, et al. Neurol Sci. 2019 Nov;40(11):2267-2275. doi: 10.1007/s10072-019-03995-0. Epub 2019 Jul 2. Neurol Sci. 2019. PMID: 31267305 - Statin Use and Outcomes of Patients With Acute Ischemic Stroke Treated With Intravenous Thrombolysis: A Systematic Review and Meta-Analysis.
Guo Y, Guo X, Zhao K, Bao Q, Yang J, Yang M. Guo Y, et al. Front Neurol. 2021 Sep 22;12:734927. doi: 10.3389/fneur.2021.734927. eCollection 2021. Front Neurol. 2021. PMID: 34630305 Free PMC article. - Impact of Traditional and Non-Traditional Lipid Parameters on Outcomes after Intravenous Thrombolysis in Acute Ischemic Stroke.
Ming C, Toh EMS, Yap QV, Yeo LLL, Sia CH, Ho AFW, Chan YH, Nastar FA, Lim AYL, Tan BYQ. Ming C, et al. J Clin Med. 2022 Dec 1;11(23):7148. doi: 10.3390/jcm11237148. J Clin Med. 2022. PMID: 36498722 Free PMC article. - Sex difference in the association between triglyceride and intracerebral bleeding risk after intravenous thrombolysis for acute ischemic stroke, a multi-center retrospective study.
Yuan Q, Han Y, Fang S, Lei H, Huang H, Lin H, Wu X, Chen R, Chen Z, Chen J, Li H, Liu N, Du H. Yuan Q, et al. PeerJ. 2024 Jun 24;12:e17558. doi: 10.7717/peerj.17558. eCollection 2024. PeerJ. 2024. PMID: 38938613 Free PMC article. - The neurovascular unit and combination treatment strategies for stroke.
Zhang L, Zhang ZG, Chopp M. Zhang L, et al. Trends Pharmacol Sci. 2012 Aug;33(8):415-22. doi: 10.1016/j.tips.2012.04.006. Epub 2012 May 16. Trends Pharmacol Sci. 2012. PMID: 22595494 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical